2014
DOI: 10.1038/ejhg.2014.24
|View full text |Cite
|
Sign up to set email alerts
|

Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome

Abstract: Tourette syndrome is a neurodevelopmental disorder characterized by multiple motor and vocal tics, and the disorder is often accompanied by comorbidities such as attention-deficit hyperactivity-disorder and obsessive compulsive disorder. Tourette syndrome has a complex etiology, but the underlying environmental and genetic factors are largely unknown. IMMP2L (inner mitochondrial membrane peptidase, subunit 2) located on chromosome 7q31 is one of the genes suggested as a susceptibility factor in disease pathoge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
62
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(63 citation statements)
references
References 40 publications
0
62
0
1
Order By: Relevance
“…Additionally, USP30 has been linked to Parkinson disease owing to its ability to oppose parkin-mediated mitophagy 96 , whereas the oligopeptidase PITRM1 has been implicated in Alzheimer disease, being the main peptidase involved in the degradation of mitochondrial amyloid-β aggregates 45 . Moreover, intragenic deletions in IMMP2L cause Tourette syndrome, whereas several SNPs and copy number variations in this gene have been associated with autism and a wide range of other neurodevelopmental disorders [131][132][133] .…”
Section: Mitoproteases and Human Diseasesmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, USP30 has been linked to Parkinson disease owing to its ability to oppose parkin-mediated mitophagy 96 , whereas the oligopeptidase PITRM1 has been implicated in Alzheimer disease, being the main peptidase involved in the degradation of mitochondrial amyloid-β aggregates 45 . Moreover, intragenic deletions in IMMP2L cause Tourette syndrome, whereas several SNPs and copy number variations in this gene have been associated with autism and a wide range of other neurodevelopmental disorders [131][132][133] .…”
Section: Mitoproteases and Human Diseasesmentioning
confidence: 99%
“…Notably, USP30 inhibitors have also been shown to promote mitochondrial fusion and to restore the mitochondrial network and oxidative respiration in cells that are deficient in mitofusins 81 . There are also cases in which the clinical applications must be based on the restoration of the activity of mitoproteases that are downregulated or inactivated in the development or progression of certain pathologies, including many hereditary diseases of mitochondrial proteolysis 131,143,148 . Consequently, either pharmacological activation or inhibition of mitoproteases will be required to treat these conditions.…”
Section: Box 1 | Clinical Implications Derived From Studies On Mitoprmentioning
confidence: 99%
“…IMMP2L is a candidate for behavioral disorders, including Gilles de la Tourette syndrome (OMIM #137580) [Bertelsen et al, 2014;Gimelli et al, 2014]. In this condition multiple motor and vocal tics are described that impact language processing [Frank, 1978].…”
Section: Sz and (The Evolution Of) Human Languagementioning
confidence: 99%
“…Intragenic losses may also affect the expression of alternative splicing variants and consequently alter cellular phenotypes [Bertelsen et al, 2014;Wang et al, 2014]. Thus, a de novo heterozygous 677-kb loss in a patient with ASD ( figs.…”
Section: Gene Truncation and Loss Of Alternative Transcriptsmentioning
confidence: 99%